Literature DB >> 35040888

Mortality, In-Hospital Morbidity, Care Practices, and 2-Year Outcomes for Extremely Preterm Infants in the US, 2013-2018.

Edward F Bell1, Susan R Hintz2, Nellie I Hansen3, Carla M Bann3, Myra H Wyckoff4, Sara B DeMauro5, Michele C Walsh6, Betty R Vohr7, Barbara J Stoll8, Waldemar A Carlo9, Krisa P Van Meurs2, Matthew A Rysavy10, Ravi M Patel8, Stephanie L Merhar11, Pablo J Sánchez12, Abbot R Laptook7, Anna Maria Hibbs13, C Michael Cotten14, Carl T D'Angio15, Sarah Winter16, Janell Fuller17, Abhik Das18.   

Abstract

IMPORTANCE: Despite improvement during recent decades, extremely preterm infants continue to contribute disproportionately to neonatal mortality and childhood morbidity.
OBJECTIVE: To review survival, in-hospital morbidities, care practices, and neurodevelopmental and functional outcomes at 22-26 months' corrected age for extremely preterm infants. DESIGN, SETTING, AND PARTICIPANTS: Prospective registry for extremely preterm infants born at 19 US academic centers that are part of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. The study included 10 877 infants born at 22-28 weeks' gestational age between January 1, 2013, and December 31, 2018, including 2566 infants born before 27 weeks between January 1, 2013, and December 31, 2016, who completed follow-up assessments at 22-26 months' corrected age. The last assessment was completed on August 13, 2019. Outcomes were compared with a similar cohort of infants born in 2008-2012 adjusting for gestational age. EXPOSURES: Extremely preterm birth. MAIN OUTCOMES AND MEASURES: Survival and 12 in-hospital morbidities were assessed, including necrotizing enterocolitis, infection, intracranial hemorrhage, retinopathy of prematurity, and bronchopulmonary dysplasia. Infants were assessed at 22-26 months' corrected age for 12 health and functional outcomes, including neurodevelopment, cerebral palsy, vision, hearing, rehospitalizations, and need for assistive devices.
RESULTS: The 10 877 infants were 49.0% female and 51.0% male; 78.3% (8495/10848) survived to discharge, an increase from 76.0% in 2008-2012 (adjusted difference, 2.0%; 95% CI, 1.0%-2.9%). Survival to discharge was 10.9% (60/549) for live-born infants at 22 weeks and 94.0% (2267/2412) at 28 weeks. Survival among actively treated infants was 30.0% (60/200) at 22 weeks and 55.8% (535/958) at 23 weeks. All in-hospital morbidities were more likely among infants born at earlier gestational ages. Overall, 8.9% (890/9956) of infants had necrotizing enterocolitis, 2.4% (238/9957) had early-onset infection, 19.9% (1911/9610) had late-onset infection, 14.3% (1386/9705) had severe intracranial hemorrhage, 12.8% (1099/8585) had severe retinopathy of prematurity, and 8.0% (666/8305) had severe bronchopulmonary dysplasia. Among 2930 surviving infants with gestational ages of 22-26 weeks eligible for follow-up, 2566 (87.6%) were examined. By 2-year follow-up, 8.4% (214/2555) of children had moderate to severe cerebral palsy, 1.5% (38/2555) had bilateral blindness, 2.5% (64/2527) required hearing aids or cochlear implants, 49.9% (1277/2561) had been rehospitalized, and 15.4% (393/2560) required mobility aids or other supportive devices. Among 2458 fully evaluated infants, 48.7% (1198/2458) had no or mild neurodevelopmental impairment at follow-up, 29.3% (709/2419) had moderate neurodevelopmental impairment, and 21.2% (512/2419) had severe neurodevelopmental impairment. CONCLUSIONS AND RELEVANCE: Among extremely preterm infants born in 2013-2018 and treated at 19 US academic medical centers, 78.3% survived to discharge, a significantly higher rate than for infants born in 2008-2012. Among infants born at less than 27 weeks' gestational age, rehospitalization and neurodevelopmental impairment were common at 2 years of age.

Entities:  

Mesh:

Year:  2022        PMID: 35040888      PMCID: PMC8767441          DOI: 10.1001/jama.2021.23580

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   157.335


  36 in total

1.  Parental Perspectives Regarding Outcomes of Very Preterm Infants: Toward a Balanced Approach.

Authors:  Magdalena Jaworski; Annie Janvier; Francine Lefebvre; Thuy Mai Luu
Journal:  J Pediatr       Date:  2018-04-25       Impact factor: 4.406

2.  Survival and Neurodevelopmental Outcomes among Periviable Infants.

Authors:  Noelle Younge; Ricki F Goldstein; Carla M Bann; Susan R Hintz; Ravi M Patel; P Brian Smith; Edward F Bell; Matthew A Rysavy; Andrea F Duncan; Betty R Vohr; Abhik Das; Ronald N Goldberg; Rosemary D Higgins; C Michael Cotten
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

3.  Outcomes and care practices for preterm infants born at less than 33 weeks' gestation: a quality-improvement study.

Authors:  Shoo K Lee; Marc Beltempo; Douglas D McMillan; Mary Seshia; Nalini Singhal; Kimberly Dow; Khalid Aziz; Bruno Piedboeuf; Prakesh S Shah
Journal:  CMAJ       Date:  2020-01-27       Impact factor: 8.262

Review 4.  Measuring and communicating meaningful outcomes in neonatology: A family perspective.

Authors:  Annie Janvier; Barbara Farlow; Jason Baardsnes; Rebecca Pearce; Keith J Barrington
Journal:  Semin Perinatol       Date:  2016-10-26       Impact factor: 3.300

5.  Determinants of developmental outcomes in a very preterm Canadian cohort.

Authors:  Anne Synnes; Thuy Mai Luu; Diane Moddemann; Paige Church; David Lee; Michael Vincer; Marilyn Ballantyne; Annette Majnemer; Dianne Creighton; Junmin Yang; Reginald Sauve; Saroj Saigal; Prakesh Shah; Shoo K Lee
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2016-10-06       Impact factor: 5.747

6.  Changes in Neurodevelopmental Outcomes From Age 2 to 10 Years for Children Born Extremely Preterm.

Authors:  Genevieve L Taylor; Robert M Joseph; Karl C K Kuban; Laurie M Douglass; Jeff Laux; Bree Andrews; Rebecca C Fry; Wayne A Price; Thomas M O'Shea
Journal:  Pediatrics       Date:  2021-04-06       Impact factor: 7.124

7.  The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach.

Authors:  Erik A Jensen; Kevin Dysart; Marie G Gantz; Scott McDonald; Nicolas A Bamat; Martin Keszler; Haresh Kirpalani; Matthew M Laughon; Brenda B Poindexter; Andrea F Duncan; Bradley A Yoder; Eric C Eichenwald; Sara B DeMauro
Journal:  Am J Respir Crit Care Med       Date:  2019-09-15       Impact factor: 21.405

Review 8.  Assessment of long-term neurodevelopmental outcome following trials of medicinal products in newborn infants.

Authors:  Neil Marlow; Lex W Doyle; Peter Anderson; Samantha Johnson; Varsha Bhatt-Mehta; Giancarlo Natalucci; Brian A Darlow; Jonathan M Davis; Mark A Turner
Journal:  Pediatr Res       Date:  2019-08-09       Impact factor: 3.756

9.  Changes in survival and neurodevelopmental outcomes of infants born at <25 weeks' gestation: a retrospective observational study in tertiary centres in Japan.

Authors:  Yumi Kono; Naohiro Yonemoto; Hidehiko Nakanishi; Satoshi Kusuda; Masanori Fujimura
Journal:  BMJ Paediatr Open       Date:  2018-01-20

Review 10.  Is survival and neurodevelopmental impairment at 2 years of age the gold standard outcome for neonatal studies?

Authors:  Neil Marlow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2014-10-10       Impact factor: 5.747

View more
  16 in total

1.  Contributions of the NICHD neonatal research network's generic database to documenting and advancing the outcomes of extremely preterm infants.

Authors:  Edward F Bell; Barbara J Stoll; Nellie I Hansen; Myra H Wyckoff; Michele C Walsh; Pablo J Sánchez; Matthew A Rysavy; Jenna H Gabrio; Stephanie W Archer; Abhik Das; Rosemary D Higgins
Journal:  Semin Perinatol       Date:  2022-06-10       Impact factor: 3.311

2.  Trends in Active Treatment of Live-born Neonates Between 22 Weeks 0 Days and 25 Weeks 6 Days by Gestational Age and Maternal Race and Ethnicity in the US, 2014 to 2020.

Authors:  Kartik K Venkatesh; Courtney D Lynch; Maged M Costantine; Carl H Backes; Jonathan L Slaughter; Heather A Frey; Xiaoning Huang; Mark B Landon; Mark A Klebanoff; Sadiya S Khan; William A Grobman
Journal:  JAMA       Date:  2022-08-16       Impact factor: 157.335

3.  Active Treatment of Infants Born at 22-25 Weeks of Gestation in California, 2011-2018.

Authors:  Xuxin Chen; Tianyao Lu; Jeffrey Gould; Susan R Hintz; Deirdre J Lyell; Xiao Xu; Lillian Sie; Matthew Rysavy; Alexis S Davis; Henry C Lee
Journal:  J Pediatr       Date:  2022-06-15       Impact factor: 6.314

4.  Correction to Nonauthor Collaborators Supplement.

Authors: 
Journal:  JAMA       Date:  2022-06-07       Impact factor: 157.335

5.  Anxiety, Depression, and Behavioral and/or Conduct Disorder in Adolescence Among Former Preterm and Term Infants of Different Race and Ethnicities.

Authors:  Nahed O ElHassan; Richard W Hall; Billy R Thomas; Timothy W Palmer; Jeffrey R Kaiser; Chenghui Li
Journal:  J Racial Ethn Health Disparities       Date:  2022-05-16

6.  Alarm Burden in Infants With Bronchopulmonary Dysplasia Monitored With Pulse Oximetry at Home.

Authors:  Heidi M Herrick; Molly Passarella; James Weimer; Christopher P Bonafide; Sara B DeMauro
Journal:  JAMA Netw Open       Date:  2022-06-01

7.  Dynamic Changes of the Gut Microbiota in Preterm Infants With Different Gestational Age.

Authors:  Qiong Jia; Xue Yu; Yanmei Chang; Yanxia You; Zekun Chen; Ying Wang; Bin Liu; Lijun Chen; Defu Ma; Yan Xing; Xiaomei Tong
Journal:  Front Microbiol       Date:  2022-06-30       Impact factor: 6.064

Review 8.  Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?

Authors:  Venkatakrishna Kakkilaya; Kanekal Suresh Gautham
Journal:  Pediatr Res       Date:  2022-08-19       Impact factor: 3.953

9.  Association of Corpus Callosum Development With Fetal Growth Restriction and Maternal Preeclampsia or Gestational Hypertension.

Authors:  Weizeng Zheng; Xiaodan Zhang; Yan Feng; Bingqing Liu; Jiajun Zhu; Yu Zou; Jiale Qin; Baohua Li
Journal:  JAMA Netw Open       Date:  2022-08-01

10.  The cerebrospinal fluid proteome of preterm infants predicts neurodevelopmental outcome.

Authors:  Kristin Leifsdottir; Kerstin Jost; Veronica Siljehav; Eric P Thelin; Philipp Lassarén; Peter Nilsson; Ásgeir Haraldsson; Staffan Eksborg; Eric Herlenius
Journal:  Front Pediatr       Date:  2022-07-19       Impact factor: 3.569

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.